Acute Aortic Syndrome in a patient with COVID-19

Joao Campos Cunha, Antonio Jose Cruz, Beatriz Madureira, Yolanda Martins, Goncalo Sarmento


The global effects of the COVID-19 pandemic make it of the utmost importance to comprehend its mechanisms and define strategies for the most effective approach possible. The SARS-CoV-2 virus can be responsible for the induction of a hypercoagulable state, which can trigger vascular phenomena of venous etiology, specifically deep venous thrombosis or pulmonary embolism. Arterial thrombotic events associated with COVID-19 have also been described in the medical literature, although less frequently. In this paper the authors report the case of a 66-year-old man who was diagnosed with an Acute Aortic Syndrome, specifically an intramural thrombus on the aortic arch, while he was still infected with the virus. Anticoagulation with low weight molecular heparin was initiated and the patient was admitted at the Internal Medicine ward for a conservative therapeutic approach. The thrombus remained stable on a serial imaging evaluation; therefore, the patient was discharged with oral anticoagulation with subsequent follow-up in the outpatient clinic. This case describes a rare and potentially serious complication of COVID-19, which highlights how broad its clinical spectrum can be, affecting systems other than the pulmonary.


SARS-CoV-2; Acute aortic syndrome; COVID-19; Anticoagulation

Full Text:



Carpenter SW, Kodolitsch YV, Debus ES, et al. Acute aortic syndromes: definition, prognosis and treatment options. J Cardiovasc Surg (Torino). 2014;55(2 Suppl 1):133-144. PMID: 24796906.

Vulliamy P, Jacob S, Davenport RA. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19. Br J Haematol. 2020;189(6):1053-1054. doi: 10.1111/bjh.16760. PMID: 32353183; PMCID: PMC7267618.

McBane RD 2nd. Arterial Thrombosis and Coronavirus Disease 2019. Mayo Clin Proc. 2021;96(2):274-276. doi: 10.1016/j.mayocp.2020.12.009. PMID: 33549245; PMCID: PMC7758023.

Fournier M, Faille D, Dossier A, et al. Arterial Thrombotic Events in Adult Inpatients With COVID-19. Mayo Clin Proc. 2021;96(2):295-303. doi: 10.1016/j.mayocp.2020.11.018. PMID: 33549252; PMCID: PMC7691140.

Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147. doi: 10.1016/j.thromres.2020.04.013. PMID: 32291094; PMCID: PMC7146714.

Iba T, Levy JH, Connors JM, et al. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360. doi: 10.1186/s13054-020-03077-0. PMID: 32552865; PMCID: PMC7301352.

Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-1120. doi: 10.1515/cclm-2020-0188. PMID: 32172226.

Singh DP, Basit H, Malik A, et al. Mural Thrombi. [Updated 2022 Jul 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: [Available at 03/18/2023]

Kashi M, Jacquin A, Dakhil B, et al. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020;192:75-77. doi: 10.1016/j.thromres.2020.05.025. PMID: 32425264; PMCID: PMC7229939.

Al-Mashdali AF, Al-Dubai HN, Al-Warqi AF. Aortic arch thrombosis complicated by an embolic stroke in a patient with COVID-19: A case report. Ann Med Surg (Lond). 2021;69:102760. doi: 10.1016/j.amsu.2021.102760. PMID: 34457268; PMCID: PMC8381619.


Copyright (c) 2023 Joao Campos Cunha, Antonio Jose Cruz, Beatriz Madureira, Yolanda Martins, Goncalo Sarmento

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975